Hereditary Transthyretin Amyloidosis (HATTR) Market Report

Global and Region Hereditary Transthyretin Amyloidosis (HATTR) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：222
  • REPORT CODE：GMM905838
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Hereditary Transthyretin Amyloidosis (HATTR) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Hereditary Transthyretin Amyloidosis (HATTR)market, defines the market attractiveness level of Hereditary Transthyretin Amyloidosis (HATTR) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Hereditary Transthyretin Amyloidosis (HATTR) industry, describes the types of Hereditary Transthyretin Amyloidosis (HATTR) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hereditary Transthyretin Amyloidosis (HATTR) market and the development prospects and opportunities of Hereditary Transthyretin Amyloidosis (HATTR) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hereditary Transthyretin Amyloidosis (HATTR) market in Chapter 13.

    By Player:

    • Prothena

    • Pfizer

    • Alnylam Pharmaceuticals

    • Akcea Therapeutics

    • Eidos Therapeutics

    • Lonis Pharmaceuticals

    • Corino Therapeutics Inc

    By Type:

    • Oral

    • Subcutaneous Injection

    • Others

    By End-User:

    • Hospital

    • Clinic

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Hereditary Transthyretin Amyloidosis (HATTR) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Hereditary Transthyretin Amyloidosis (HATTR) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Hereditary Transthyretin Amyloidosis (HATTR) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Hereditary Transthyretin Amyloidosis (HATTR) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Hereditary Transthyretin Amyloidosis (HATTR) Market Analysis and Outlook to 2022

    • 7.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption (2017-2022)

    • 7.2 United States Hereditary Transthyretin Amyloidosis (HATTR) Consumption (2017-2022)

    • 7.3 Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption (2017-2022)

    • 7.4 China Hereditary Transthyretin Amyloidosis (HATTR) Consumption (2017-2022)

    • 7.5 Japan Hereditary Transthyretin Amyloidosis (HATTR) Consumption (2017-2022)

    • 7.6 India Hereditary Transthyretin Amyloidosis (HATTR) Consumption (2017-2022)

    • 7.7 South Korea Hereditary Transthyretin Amyloidosis (HATTR) Consumption (2017-2022)

    8 Region and Country-wise Hereditary Transthyretin Amyloidosis (HATTR) Market Analysis and Outlook to 2028

    • 8.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Forecast (2022-2028)

    • 8.2 United States Hereditary Transthyretin Amyloidosis (HATTR) Consumption Forecast (2022-2028)

    • 8.3 Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Forecast (2022-2028)

    • 8.4 China Hereditary Transthyretin Amyloidosis (HATTR) Consumption Forecast (2022-2028)

    • 8.5 Japan Hereditary Transthyretin Amyloidosis (HATTR) Consumption Forecast (2022-2028)

    • 8.6 India Hereditary Transthyretin Amyloidosis (HATTR) Consumption Forecast (2022-2028)

    • 8.7 South Korea Hereditary Transthyretin Amyloidosis (HATTR) Consumption Forecast (2022-2028)

    9 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Outlook by Types and Applications to 2022

    • 9.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Oral Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Subcutaneous Injection Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Outlook by Types and Applications to 2028

    • 10.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Hereditary Transthyretin Amyloidosis (HATTR) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Hereditary Transthyretin Amyloidosis (HATTR) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Competitive Analysis

    • 14.1 Prothena

      • 14.1.1 Prothena Company Details

      • 14.1.2 Prothena Hereditary Transthyretin Amyloidosis (HATTR) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Prothena Hereditary Transthyretin Amyloidosis (HATTR) Product and Service

    • 14.2 Pfizer

      • 14.2.1 Pfizer Company Details

      • 14.2.2 Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Product and Service

    • 14.3 Alnylam Pharmaceuticals

      • 14.3.1 Alnylam Pharmaceuticals Company Details

      • 14.3.2 Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product and Service

    • 14.4 Akcea Therapeutics

      • 14.4.1 Akcea Therapeutics Company Details

      • 14.4.2 Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product and Service

    • 14.5 Eidos Therapeutics

      • 14.5.1 Eidos Therapeutics Company Details

      • 14.5.2 Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product and Service

    • 14.6 Lonis Pharmaceuticals

      • 14.6.1 Lonis Pharmaceuticals Company Details

      • 14.6.2 Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product and Service

    • 14.7 Corino Therapeutics Inc

      • 14.7.1 Corino Therapeutics Inc Company Details

      • 14.7.2 Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Hereditary Transthyretin Amyloidosis (HATTR)

    • Figure Hereditary Transthyretin Amyloidosis (HATTR) Picture

    • Table Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Hereditary Transthyretin Amyloidosis (HATTR) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption by Country (2017-2022)

    • Figure United States Hereditary Transthyretin Amyloidosis (HATTR) Consumption and Growth Rate (2017-2022)

    • Table Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption and Growth Rate (2017-2022)

    • Figure China Hereditary Transthyretin Amyloidosis (HATTR) Consumption and Growth Rate (2017-2022)

    • Figure Japan Hereditary Transthyretin Amyloidosis (HATTR) Consumption and Growth Rate (2017-2022)

    • Figure India Hereditary Transthyretin Amyloidosis (HATTR) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Hereditary Transthyretin Amyloidosis (HATTR) Consumption and Growth Rate (2017-2022)

    • Figure Global Hereditary Transthyretin Amyloidosis (HATTR) Consumption Forecast by Country (2022-2028)

    • Figure United States Hereditary Transthyretin Amyloidosis (HATTR) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Hereditary Transthyretin Amyloidosis (HATTR) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Hereditary Transthyretin Amyloidosis (HATTR) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Hereditary Transthyretin Amyloidosis (HATTR) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Hereditary Transthyretin Amyloidosis (HATTR) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Hereditary Transthyretin Amyloidosis (HATTR) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oral Consumption and Growth Rate (2017-2022)

    • Figure Global Subcutaneous Injection Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Subcutaneous Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Hereditary Transthyretin Amyloidosis (HATTR) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Hereditary Transthyretin Amyloidosis (HATTR) Export by Region (Top 5 Countries) (2017-2028)

    • Table Prothena (Foundation Year, Company Profile and etc.)

    • Table Prothena Hereditary Transthyretin Amyloidosis (HATTR) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Prothena Hereditary Transthyretin Amyloidosis (HATTR) Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Product and Service

    • Table Alnylam Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product and Service

    • Table Akcea Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product and Service

    • Table Eidos Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product and Service

    • Table Lonis Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product and Service

    • Table Corino Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US